- Home
- TRVI vs SEAT Comparison
TRVI vs SEAT Comparison
Compare TRVI & SEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- SEAT
- Stock Information
- Founded
- TRVI 2011
- SEAT 2001
- Country
- TRVI United States
- SEAT United States
- Employees
- TRVI N/A
- SEAT N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- SEAT Industrial Machinery/Components
- Sector
- TRVI Health Care
- SEAT Industrials
- Exchange
- TRVI Nasdaq
- SEAT Nasdaq
- Market Cap
- TRVI 383.4M
- SEAT 366.2M
- IPO Year
- TRVI 2019
- SEAT N/A
- Fundamental
- Price
- TRVI $6.07
- SEAT $2.31
- Analyst Decision
- TRVI Strong Buy
- SEAT Buy
- Analyst Count
- TRVI 8
- SEAT 11
- Target Price
- TRVI $17.56
- SEAT $5.58
- AVG Volume (30 Days)
- TRVI 1.6M
- SEAT 1.9M
- Earning Date
- TRVI 05-06-2025
- SEAT 05-06-2025
- Dividend Yield
- TRVI N/A
- SEAT N/A
- EPS Growth
- TRVI N/A
- SEAT N/A
- EPS
- TRVI N/A
- SEAT 0.06
- Revenue
- TRVI N/A
- SEAT $775,586,000.00
- Revenue This Year
- TRVI N/A
- SEAT N/A
- Revenue Next Year
- TRVI N/A
- SEAT $5.80
- P/E Ratio
- TRVI N/A
- SEAT $41.05
- Revenue Growth
- TRVI N/A
- SEAT 8.80
- 52 Week Low
- TRVI $2.30
- SEAT $2.36
- 52 Week High
- TRVI $7.39
- SEAT $6.09
- Technical
- Relative Strength Index (RSI)
- TRVI 54.54
- SEAT 32.58
- Support Level
- TRVI $4.85
- SEAT $2.36
- Resistance Level
- TRVI $6.15
- SEAT $2.90
- Average True Range (ATR)
- TRVI 0.50
- SEAT 0.23
- MACD
- TRVI -0.04
- SEAT 0.01
- Stochastic Oscillator
- TRVI 73.94
- SEAT 0.66
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About SEAT Vivid Seats Inc.
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.